Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Laboratory Model to Screen Drugs With Opioid Analgesic-sparing Effects: Cannabidiol/Morphine Combinations

NCT04030442 is registered in ClinicalTrials.gov with Wayne State University as lead sponsor.

NCT NCT04030442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04030442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Laboratory Model to Screen Drugs With Opioid Analgesic-sparing Effects: Cannabidiol/Morphine Combinations
Lead sponsor
Wayne State University
Phase
Phase 1
Overall status
Unknown status
Start date
May 1, 2019
Completion date
January 26, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cbd, chronic pain